Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

The prevalence of substance-induced psychotic disorder in methamphetamine misusers: A meta-analysis.

Lecomte T, Dumais A, Dugré JR, Potvin S.

Psychiatry Res. 2018 May 17;268:189-192. doi: 10.1016/j.psychres.2018.05.033. [Epub ahead of print]

PMID:
30041133
2.

Acceptance and Commitment Therapy for Psychosis and Trauma: Investigating Links between Trauma Severity, Attachment and Outcome.

Spidel A, Daigneault I, Kealy D, Lecomte T.

Behav Cogn Psychother. 2018 Jul 17:1-14. doi: 10.1017/S1352465818000413. [Epub ahead of print]

PMID:
30012233
3.

Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.

Lièvre A, Ouine B, Canet J, Cartier A, Amar Y, Cacheux W, Mariani O, Guimbaud R, Selves J, Lecomte T, Guyetant S, Bieche I, Berger F, de Koning L.

Br J Cancer. 2018 Jun 14. doi: 10.1038/s41416-018-0130-x. [Epub ahead of print]

PMID:
29899390
4.

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.

Aparicio T, Ducreux M, Faroux R, Barbier E, Manfredi S, Lecomte T, Etienne PL, Bedenne L, Bennouna J, Phelip JM, François E, Michel P, Legoux JL, Gasmi M, Breysacher G, Rougier P, De Gramont A, Lepage C, Bouché O, Seitz JF; for FFCD investigators.

Eur J Cancer. 2018 Jul;98:1-9. doi: 10.1016/j.ejca.2018.03.031. Epub 2018 May 26.

5.

Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer.

Aparicio T, Bouché O, Francois E, Retornaz F, Barbier E, Taieb J, Kirscher S, Etienne PL, Faroux R, Khemissa Akouz F, El Hajbi F, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Bedenne L, Paillaud E; for PRODIGE 20 investigators.

Eur J Cancer. 2018 Jul;97:16-24. doi: 10.1016/j.ejca.2018.03.030. Epub 2018 May 16.

PMID:
29777975
6.

Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity.

Anon B, Largeau B, Girault A, Chantome A, Caulet M, Perray C, Moussata D, Vandier C, Barin-Le Guellec C, Lecomte T.

Cancer Chemother Pharmacol. 2018 Jul;82(1):149-157. doi: 10.1007/s00280-018-3600-1. Epub 2018 May 17.

PMID:
29774408
7.

Implementing cognitive behavioral therapy for psychosis: An international survey of clinicians' attitudes and obstacles.

Lecomte T, Samson C, Naeem F, Schachte L, Farhall J.

Psychiatr Rehabil J. 2018 Jun;41(2):141-148. doi: 10.1037/prj0000292. Epub 2018 May 3.

PMID:
29723013
8.

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.

Aparicio T, Bouché O, Taieb J, Maillard E, Kirscher S, Etienne PL, Faroux R, Khemissa Akouz F, El Hajbi F, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Paillaud E, Retornaz F, François E, Bedenne L; for PRODIGE 20 Investigators.

Ann Oncol. 2018 Apr 30. doi: 10.1093/annonc/mdx808. [Epub ahead of print] No abstract available.

PMID:
29718089
9.

Psychotic disorders in sexually abused youth: A prospective matched-cohort study.

Bourgeois C, Lecomte T, Daigneault I.

Schizophr Res. 2018 Mar 13. pii: S0920-9964(18)30172-5. doi: 10.1016/j.schres.2018.03.020. [Epub ahead of print]

PMID:
29548761
10.

RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study.

Bachet JB, Bouché O, Taieb J, Dubreuil O, Garcia ML, Meurisse A, Normand C, Gornet JM, Artru P, Louafi S, Bonnetain F, Thirot-Bidault A, Baumgaertner I, Coriat R, Tougeron D, Lecomte T, Mary F, Aparicio T, Marthey L, Taly V, Blons H, Vernerey D, Laurent-Puig P.

Ann Oncol. 2018 May 1;29(5):1211-1219. doi: 10.1093/annonc/mdy061.

PMID:
29438522
11.

Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis.

Potvin S, Pelletier J, Grot S, Hébert C, Barr AM, Lecomte T.

Addict Behav. 2018 May;80:154-160. doi: 10.1016/j.addbeh.2018.01.021. Epub 2018 Jan 31. Review.

PMID:
29407687
12.

Development and validation of an ELISA to study panitumumab pharmacokinetics.

Desvignes C, Passot C, Ternant D, Caulet M, Guérineau C, Lecomte T, Paintaud G.

Bioanalysis. 2018 Feb;10(4):205-214. doi: 10.4155/bio-2016-0292. Epub 2018 Jan 18.

PMID:
29345521
13.

Pharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumab.

Ibrahim S, Raoul W, Lecomte T, Paintaud G, Ternant D.

Eur J Cancer. 2018 Mar;92:119-120. doi: 10.1016/j.ejca.2017.12.004. Epub 2018 Jan 9. No abstract available.

PMID:
29329696
14.

[Return to Work Strategies of Employees who Experienced Depression: Employers and HR's Perspectives].

Corbière M, Lecomte T, Lachance JP, Coutu MF, Negrini A, Laberon S.

Sante Ment Que. Fall 2017;42(2):173-196. French.

PMID:
29267420
15.
16.

Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study.

Palle J, Tougeron D, Pozet A, Soularue E, Artru P, Leroy F, Dubreuil O, Sarabi M, Williet N, Manfredi S, Martin-Babau J, Rebischung C, Abdelghani MB, Evesque L, Dreanic J, Hautefeuille V, Louafi S, Sefrioui D, Savinelli F, Mabro M, Rousseau B, Lecaille C, Bouché O, Louvet C, Lecomte T, Bonnetain F, Taieb J, Zaanan A.

Oncotarget. 2017 Sep 8;8(60):101383-101393. doi: 10.18632/oncotarget.20711. eCollection 2017 Nov 24.

17.

Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration.

Ternant D, Passot C, Aubourg A, Goupille P, Desvignes C, Picon L, Lecomte T, Mulleman D, Paintaud G.

Clin Pharmacokinet. 2018 Sep;57(9):1173-1184. doi: 10.1007/s40262-017-0621-6.

PMID:
29236229
18.

Value of Contrast-Enhanced Ultrasound Quantification Criteria for Identifying Patients not Responding to Bevacizumab-Based Therapy for Colorectal Liver Metastases.

Tranquart F, Dujardin PA, Bouché O, Marcus C, Borg C, Manzoni P, Douillard JY, Labbe-Devilliers C, Terrebonne E, Smith D, Trillaud H, Capitain O, Aubé C, Spano JP, Lucidarme O, Ferru A, Tasu JP, Manfredi S, Bleuzen A, Léger J, Lecomte T.

Ultraschall Med. 2017 Dec 12. doi: 10.1055/s-0043-122497. [Epub ahead of print]

PMID:
29232725
19.

Clinical outcome of portal vein thrombosis in patients with digestive cancers: A large AGEO multicenter study.

Regnault H, Emambux S, Lecomte T, Doat S, Dhooge M, Besson M, Dubreuil O, Moryoussef F, Silvain C, Bachet JB, Tougeron D.

Dig Liver Dis. 2018 Mar;50(3):285-290. doi: 10.1016/j.dld.2017.11.001. Epub 2017 Nov 16.

PMID:
29183764
20.

Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study.

Salimon M, Prieux-Klotz C, Tougeron D, Hautefeuille V, Caulet M, Gournay J, Matysiak-Budnik T, Bennouna J, Tiako Meyo M, Lecomte T, Zaanan A, Touchefeu Y.

Br J Cancer. 2018 Feb 6;118(3):325-330. doi: 10.1038/bjc.2017.413. Epub 2017 Nov 23.

PMID:
29169182
21.

Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer?

Ibrahim S, Girault A, Ohresser M, Lereclus E, Paintaud G, Lecomte T, Raoul W.

Clin Colorectal Cancer. 2018 Mar;17(1):e109-e113. doi: 10.1016/j.clcc.2017.10.003. Epub 2017 Oct 28. Review.

22.

Ca2+ protein alpha 1D of CaV1.3 regulates intracellular calcium concentration and migration of colon cancer cells through a non-canonical activity.

Fourbon Y, Guéguinou M, Félix R, Constantin B, Uguen A, Fromont G, Lajoie L, Magaud C, Lecomte T, Chamorey E, Chatelier A, Mignen O, Potier-Cartereau M, Chantôme A, Bois P, Vandier C.

Sci Rep. 2017 Oct 27;7(1):14199. doi: 10.1038/s41598-017-14230-1.

23.

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.

Aparicio T, Bouché O, Taieb J, Maillard E, Kirscher S, Etienne PL, Faroux R, Khemissa Akouz F, El Hajbi F, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Paillaud E, Retornaz F, François E, Bedenne L; for PRODIGE 20 Investigators.

Ann Oncol. 2018 Jan 1;29(1):133-138. doi: 10.1093/annonc/mdx529.

24.

Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.

Lièvre A, Ouine B, Canet J, Cartier A, Amar Y, Cacheux W, Mariani O, Guimbaud R, Selves J, Lecomte T, Guyetant S, Bieche I, Berger F, de Koning L.

Br J Cancer. 2017 Dec 5;117(12):1819-1827. doi: 10.1038/bjc.2017.353. Epub 2017 Oct 12. Erratum in: Br J Cancer. 2018 Jun 14;:.

25.

Acceptance and commitment therapy for psychosis and trauma: Improvement in psychiatric symptoms, emotion regulation, and treatment compliance following a brief group intervention.

Spidel A, Lecomte T, Kealy D, Daigneault I.

Psychol Psychother. 2018 Jun;91(2):248-261. doi: 10.1111/papt.12159. Epub 2017 Oct 4.

PMID:
28976056
26.

A serial mediation model of workplace social support on work productivity: the role of self-stigma and job tenure self-efficacy in people with severe mental disorders.

Villotti P, Corbière M, Dewa CS, Fraccaroli F, Sultan-Taïeb H, Zaniboni S, Lecomte T.

Disabil Rehabil. 2017 Sep 12:1-7. doi: 10.1080/09638288.2017.1377294. [Epub ahead of print]

PMID:
28899202
27.

Canadian Treatment Guidelines on Psychosocial Treatment of Schizophrenia in Children and Youth.

Lecomte T, Abidi S, Garcia-Ortega I, Mian I, Jackson K, Jackson K, Norman R.

Can J Psychiatry. 2017 Sep;62(9):648-655. doi: 10.1177/0706743717720195. Review.

28.

Measurement of Telomere Length in Colorectal Cancers for Improved Molecular Diagnosis.

Balc'h EL, Grandin N, Demattei MV, Guyétant S, Tallet A, Pagès JC, Ouaissi M, Lecomte T, Charbonneau M.

Int J Mol Sci. 2017 Aug 29;18(9). pii: E1871. doi: 10.3390/ijms18091871.

29.

BioFlow: a non-invasive, image-based method to measure speed, pressure and forces inside living cells.

Boquet-Pujadas A, Lecomte T, Manich M, Thibeaux R, Labruyère E, Guillén N, Olivo-Marin JC, Dufour AC.

Sci Rep. 2017 Aug 23;7(1):9178. doi: 10.1038/s41598-017-09240-y.

30.

Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth.

Abidi S, Mian I, Garcia-Ortega I, Lecomte T, Raedler T, Jackson K, Jackson K, Pringsheim T, Addington D.

Can J Psychiatry. 2017 Sep;62(9):635-647. doi: 10.1177/0706743717720197. Epub 2017 Aug 2. Review.

31.

Symptom fluctuations, self-esteem, and cohesion during group cognitive behaviour therapy for early psychosis.

Lecomte T, Leclerc C, Wykes T.

Psychol Psychother. 2018 Mar;91(1):15-26. doi: 10.1111/papt.12139. Epub 2017 Jul 14.

PMID:
28707407
32.

Canadian Treatment Guidelines on Psychosocial Treatment of Schizophrenia in Adults.

Norman R, Lecomte T, Addington D, Anderson E.

Can J Psychiatry. 2017 Sep;62(9):617-623. doi: 10.1177/0706743717719894. Epub 2017 Jul 13. Review.

33.

Management of gastric neuro-endocrine tumours in a large French national cohort (GTE).

Manfredi S, Walter T, Baudin E, Coriat R, Ruszniewski P, Lecomte T, Laurenty AP, Goichot B, Rohmer V, Roquin G, Cojocarasu OZ, Lombard-Bohas C, Lepage C, Morcet J, Cadiot G.

Endocrine. 2017 Sep;57(3):504-511. doi: 10.1007/s12020-017-1355-9. Epub 2017 Jun 29.

34.

How Can Supervisors Contribute to the Return to Work of Employees Who have Experienced Depression?

Negrini A, Corbière M, Lecomte T, Coutu MF, Nieuwenhuijsen K, St-Arnaud L, Durand MJ, Gragnano A, Berbiche D.

J Occup Rehabil. 2018 Jun;28(2):279-288. doi: 10.1007/s10926-017-9715-0.

PMID:
28660364
35.

Narrative development and supported employment of persons with severe mental illness.

Cartwright KA, Lecomte T, Corbière M, Lysaker P.

J Ment Health. 2017 Jun 23:1-8. doi: 10.1080/09638237.2017.1340606. [Epub ahead of print]

PMID:
28644705
36.

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.

Walter T, Tougeron D, Baudin E, Le Malicot K, Lecomte T, Malka D, Hentic O, Manfredi S, Bonnet I, Guimbaud R, Coriat R, Lepère C, Desauw C, Thirot-Bidault A, Dahan L, Roquin G, Aparicio T, Legoux JL, Lombard-Bohas C, Scoazec JY, Lepage C, Cadiot G; CEPD investigators.

Eur J Cancer. 2017 Jul;79:158-165. doi: 10.1016/j.ejca.2017.04.009. Epub 2017 May 11.

PMID:
28501762
37.

Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial.

Bachet JB, Hammel P, Desramé J, Meurisse A, Chibaudel B, André T, Debourdeau P, Dauba J, Lecomte T, Seitz JF, Tournigand C, Aparicio T, Meyer VG, Taieb J, Volet J, Monier A, Bonnetain F, Louvet C.

Lancet Gastroenterol Hepatol. 2017 May;2(5):337-346. doi: 10.1016/S2468-1253(17)30046-8. Epub 2017 Feb 28.

PMID:
28397697
38.

A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification.

Boisdron-Celle M, Metges JP, Capitain O, Adenis A, Raoul JL, Lecomte T, Lam YH, Faroux R, Masliah C, Poirier AL, Berger V, Morel A, Gamelin E.

Semin Oncol. 2017 Feb;44(1):24-33. doi: 10.1053/j.seminoncol.2017.02.007. Epub 2017 Feb 9.

PMID:
28395759
39.

One parasite may be hiding another...

Broutin L, Auzoux J, Anon B, Caulet M, Aubourg A, Lecomte T, Chandenier J, Desoubeaux G.

Ann Biol Clin (Paris). 2017 Apr 1;75(2):231-232. doi: 10.1684/abc.2017.1220. No abstract available.

PMID:
28377337
40.

A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen.

Lereclus E, Tout M, Girault A, Baroukh N, Caulet M, Borg C, Bouché O, Ternant D, Paintaud G, Lecomte T, Raoul W.

BMC Cancer. 2017 Mar 27;17(1):220. doi: 10.1186/s12885-017-3210-z.

41.

Predictors of Acquisition of Competitive Employment for People Enrolled in Supported Employment Programs.

Corbière M, Lecomte T, Reinharz D, Kirsh B, Goering P, Menear M, Berbiche D, Genest K, Goldner EM.

J Nerv Ment Dis. 2017 Apr;205(4):275-282. doi: 10.1097/NMD.0000000000000612.

PMID:
28212170
42.

Does personality influence job acquisition and tenure in people with severe mental illness enrolled in supported employment programs?

Fortin G, Lecomte T, Corbière M.

J Ment Health. 2017 Jun;26(3):248-256. doi: 10.1080/09638237.2016.1276534. Epub 2017 Jan 13.

PMID:
28084116
43.

Work Accommodations and Natural Supports for Employees with Severe Mental Illness in Social Businesses: An International Comparison.

Villotti P, Corbière M, Fossey E, Fraccaroli F, Lecomte T, Harvey C.

Community Ment Health J. 2017 Oct;53(7):864-870. doi: 10.1007/s10597-016-0068-5. Epub 2016 Dec 3.

PMID:
27913895
44.

Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.

Aparicio T, Gargot D, Teillet L, Maillard E, Genet D, Cretin J, Locher C, Bouché O, Breysacher G, Seitz JF, Gasmi M, Stefani L, Ramdani M, Lecomte T, Auby D, Faroux R, Bachet JB, Lepère C, Khemissa F, Sobhani I, Boulat O, Mitry E, Jouve JL; FFCD 2001-02 investigators.

Eur J Cancer. 2017 Mar;74:98-108. doi: 10.1016/j.ejca.2016.09.029. Epub 2016 Nov 5.

PMID:
27825697
45.

Clinical, histological, and molecular risk factors for cancer recurrence in patients with stage II colon cancer.

Touchefeu Y, Provost-Dewitte M, Lecomte T, Morel A, Valo I, Mosnier JF, Bossard C, Eugène J, Duchalais E, Chetritt J, Guyetant S, Bézieau S, Senellart H, Caulet M, Cauchin E, Matysiak-Budnik T.

Eur J Gastroenterol Hepatol. 2016 Dec;28(12):1394-1399.

PMID:
27606947
46.

Bevacizumab Pharmacokinetics Influence Overall and Progression-Free Survival in Metastatic Colorectal Cancer Patients.

Caulet M, Lecomte T, Bouché O, Rollin J, Gouilleux-Gruart V, Azzopardi N, Léger J, Borg C, Douillard JY, Manfredi S, Smith D, Capitain O, Ferru A, Moussata D, Terrebone E, Paintaud G, Ternant D.

Clin Pharmacokinet. 2016 Nov;55(11):1381-1394.

PMID:
27312193
47.

The underlying inflammatory chronic disease influences infliximab pharmacokinetics.

Passot C, Mulleman D, Bejan-Angoulvant T, Aubourg A, Willot S, Lecomte T, Picon L, Goupille P, Paintaud G, Ternant D.

MAbs. 2016 Oct;8(7):1407-1416. Epub 2016 Aug 9.

48.

Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological score.

Jary M, Lecomte T, Bouché O, Kim S, Dobi E, Queiroz L, Ghiringhelli F, Etienne H, Léger J, Godet Y, Balland J, Lakkis Z, Adotevi O, Bonnetain F, Borg C, Vernerey D.

Int J Cancer. 2016 Nov 15;139(10):2325-35. doi: 10.1002/ijc.30367. Epub 2016 Aug 13.

49.

Factors limiting romantic relationship formation for individuals with early psychosis.

Pillay R, Lecomte T, Abdel-Baki A.

Early Interv Psychiatry. 2016 May 17. doi: 10.1111/eip.12353. [Epub ahead of print]

PMID:
27186857
50.

Hiatal hernia on thoracic computed tomography in pulmonary fibrosis.

Tossier C, Dupin C, Plantier L, Leger J, Flament T, Favelle O, Lecomte T, Diot P, Marchand-Adam S.

Eur Respir J. 2016 Sep;48(3):833-42. doi: 10.1183/13993003.01796-2015. Epub 2016 May 12.

Supplemental Content

Loading ...
Support Center